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MCPyV represents an exciting direc-
tion for future studies in two major
areas. The first area is functional
characterization of the MCPyV and
determination if it expresses biologi-
cally active viral proteins and whether
it is in fact involved in the generation or
maintenance of MCC tumors. The
second major direction is an epidemio-
logic characterization of the prevalence
of MCPyV in healthy people and in
various tumors as this virus may plau-
sibly be associated with other human
diseases or malignancies.
Merkel cell carcinoma specimens
were from the ‘‘Repository of Data
and Specimens for Merkel Cell
Carcinoma Research’’ at the Fred
Hutchinson Cancer Research Center.
Normal sun-exposed skin and
squamous-cell carcinoma tumors were
from the ‘‘Main Biomarker Research
Specimen Repository’’ at the University
of Washington. The relevant
Institutional Review Boards approved
this study, and this study was
performed with strict adherence
to the Declaration of Helsinki
Principles.
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TO THE EDITOR
Merkel cell carcinoma (MCC) is a rare,
but highly aggressive neuroendocrine
cancer of the skin that occurs primarily
in elderly immune-suppressed indivi-
duals. Little is known about the patho-
genesis of MCC. Now Feng et al. (2008)
have identified a new polyomavirus
present in MCC (MCPyV). In this
regard, viral proteins expressed by
polyomaviruses are known to initiate
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Figure 2. Marked variability of Merkel cell polyomavirus DNA quantity among MCC tumors. The
amount of MCPyV DNA was compared to the amount of DNA of a control gene on chromosome 2 (TPO).
Note the wide range in levels of MCPyV DNA. MCC primaries (n¼ 8, circles), recurrences (n¼ 13,
squares), nodal metastases (n¼ 15, triangles), and distant metastases (n¼1, diamond) are compared. Also
shown are squamous-cell carcinomas (ovals) and sun-exposed skin controls (pentagons). Tumors
originating from North America are represented with closed symbols and those originating from Australia
are represented with open symbols. Tumors represented as not detected had good amplification of
control gene but no detectable MCPyV by both primer sets.
See related commentary on pg 9
Abbreviations: MCC, Merkel cell carcinoma; MCPyV, Merkel cell polyomavirus
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transformation and immortalization
of cultured cells. Accordingly, in
experimental models, polyomaviruses
induced tumors upon integration of
the viral genome into the host genome
(Poulin and DeCaprio, 2006). There-
fore, the detection of MCPyV integrated
into the host genome in six out of eight
MCCs (75.0%) by Feng et al. argues
for a causative role of this polyomavirus
for MCC. Although polyomaviruses
have been discussed for a long time to
be involved in human tumorigenesis
(Poulin and DeCaprio, 2006), this
observation is the first clear hint for
their impact on tumor etiology in
humans as the other known human-
specific polyomaviruses, that is, BKPyV,
JCPyV, KIPyV, and WUPyV, have
not yet been found to be integrated
in tumor-derived genomic DNA.
Notably, the patterns of integration
indicated that viral infection by MCPyV
precedes clonal expansion of tumor
cells consistent with MCPyV’s role
in MCC.
To expand the study of Feng et al.,
we analyzed 75 samples of 53 MCC
patients for the presence of MCPyV by
real-time PCR. To this end, DNA was
obtained from formalin-fixed patient
material and samples were analyzed
for the presence of MCPyV by using
TaqMan technology with primers (for-
ward: 50-CCAAACCAAAGAATAAAGCA
CTGA-30; reverse: 50-TCGCCAGCATTGT
AGTCTAAAAAC-30) and a respective
probe (TP: FAM-AGCAAAAACACTC
TCCCCACGTCAGACAG-BHQ) specific
for the MCPyV large T-antigen gene.
The Taqman probe, for example, was
designed to have at least 11 mismatches
to the other known human-specific
polyomaviruses. By normalization to
the highly repetitive DNA elements
LINE1—for which the copy number
even in cancer cells is largely con-
stant—a relative quantification of the
samples could be calculated by the
DDCt method. These analyses demon-
strated that in the tumors of 45 patients
(84.9%) the virus was present. The
presence or absence of the virus was
concordant in consecutive samples,
that is, primary tumor and subsequent
metastases for all patients. The clinical
follow-up of a patient cohort for
which the detailed clinical course was
available suggests that MCC containing
the viral genome display a more
aggressive behavior than their virus-
negative counterparts (Table 1). How-
ever, if all patients were stratified by
tumor stage, that is, stage I or higher,
there was no significant difference
between these patient cohorts
(P¼0.4527 in Fisher’s exact test)
(Figure 1). Hence, as the rate of
MCPyV-negative tumors is low, the
impact of the MCPyV virus on clinical
course has to be revealed in a larger
patient population. It should be
further noted that of 24 basal cell
carcinomas, another skin cancer
affecting mostly elderly patients, only
three samples (12.5%) harbored
the viral genome; moreover, the
mean relative frequency of virus DNA
in the positive basal cell carcinoma
samples is about 4 log lower than
in MCC.
In summary, our study unambi-
guously confirms the association of
MCPyV with MCC reported by Feng
et al. Given the oncogenic potential of
polyomaviruses, and accounting for the
lack of systemic therapies improving
the survival of metastatic MCC, this
observation may open new therapeutic
options in this disease. Antivirals such
as IFNs (Borden et al., 2007) or—as
proteins from polyomavirus are known
to be immunogeneic (Binggeli et al.,
2007)—active immunotherapy has to
be considered.
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Table 1. Clinical course of a patient cohort for which detailed information
was available
Patient id Gender
Age at
diagnosis1
Stage at
diagnosis
Stage at
date last seen Follow-up2
Patients with MCPyV
RF M 91.4 I II 64.1
RR M 80.1 I II 9.97
BE F 68.7 I II 48.8
GW M 63.8 III III 31.7
HW M 80.9 I III 6.47
KA M 85.1 II II 3.27
ST F 81.4 I I 3.5
BR M 89.8 I I 0.0
NR M 72.6 II II 15.43
KM F 72.9 II II 26.83
HO M 79.6 I I 0.00
HW M 93.7 I III 27.5
PH F 78.8 I I 43.47
RE F 90.4 I I 1.4
KR M 63.1 III III 6.57
SB F 57.0 III III 0.00
LH M 72.9 I III 1.80
LB M 54.8 I III 9.5
Patients without MCPyV
SR M 76.8 I I 88.47
KE M 71.4 I Unknown 35.43
SM F 83.4 I I 0.00
HA F 83.1 I I 11.63
GH M 84.4 I I 10.03
F, female; M, male; MCPyV, Merkel cell polyomavirus.
1In years.
2In months. Time span between diagnosis and date last seen or date of death.
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TO THE EDITOR
Organ transplant recipients have a 100-
fold increased risk of developing
cutaneous squamous cell carcinoma
(SCC) compared to the general popula-
tion (Euvrard et al., 1993). Compared to
immunocompetent patients, organ
transplant recipients often develop
more invasive and aggressive SCCs,
with increased multiplicity, recurrence,
and risk for metastasis. In addition to
SCCs, organ transplant recipients
develop more keratoacanthomas (KAs),
Bowen’s disease, and actinic keratoses.
A potential reason for the development
of these tumors is that posttransplant
immunosuppressive medications result
in enhanced susceptibility to infection.
Histologically, many of the lesions in
these patients demonstrate the hall-
marks of viral infection such as the
presence of koilocytes and verruciform
epidermal hyperplasia (Euvrard et al.,
1993; Hsi et al., 1997; Harwood et al.,
2006).
Study of viruses in skin tumors of
transplant patients has previously fo-
cused on human papilloma virus (HPV).
PCR assays for epidermodysplasia ver-
ruciformis and mucosal serotypes of
HPV have revealed that high risk
mucosal HPVs are relatively infrequent
in these cutaneous tumors. The fre-
quency of epidermodysplasia verruci-
formis HPV infection ranges from
39–92% in SCCs from transplant pa-
tients (Berkhout et al., 1995; Boxman
et al., 1997; Hopfl et al., 1997).
However, the presence of epidermo-
dysplasia verruciformis HPV can also
be found in plucked hairs and forehead
swabs from healthy individuals and skin
tumors from immunocompetent pa-
tients (Boxman et al., 1997; Hsi et al.,
1997; McGregor et al., 1997; Hazard
et al., 2007). Thus, the exact etiologic
role that these viruses play in skin
cancer in organ transplant recipients
remains unclear. Other viruses may
also contribute to tumorigenesis in
organ-transplant patients. Recently, the
presence of polyomavirus has been
detected in 80% of Merkel cell carci-
nomas (MCCs; Feng et al., 2008). In
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Figure 1. MCPyV is more prevalent in patients with metastatic disease. The percentage of MCPyV
absence is given for patients without (primary tumor only) and with (metastasis) known metastatic
disease. The inset depicts representative results for presence (patient BE; MCV: black line;
LINE1: black dashed line) and absence (patient SM; MCV gray line; LINE1: gray dotted line) of
MCPyV in two primary tumors. LINE1 serves as DNA control.
Abbreviations: HPV, human papilloma virus; KA, keratoacanthoma; MCC, Merkel cell carcinoma; SCC,
squamous cell carcinoma
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